Ligand validation:2H00

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 2H00 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2H00_SAH_B_301	66%	24%	0.131	0.937	1.35	1.73	2	4	0	0	100%	1
2H00_SAH_A_300	60%	26%	0.124	0.909	1.24	1.73	2	6	2	0	100%	1
2H00_SAH_C_302	56%	24%	0.121	0.892	1.35	1.75	4	4	2	0	100%	1
6B92_SAH_A_305	72%	26%	0.134	0.958	1.62	1.41	6	6	2	0	100%	1
6GFK_SAH_A_301	61%	44%	0.168	0.957	1.15	1.01	3	2	0	0	100%	1
6GFN_SAH_A_300	35%	32%	0.233	0.921	1.05	1.63	2	4	0	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
8TDR_SAH_B_1001	100%	25%	0.029	0.996	1.26	1.79	3	4	0	0	100%	1
6I73_SAH_A_401	100%	49%	0.028	0.992	0.78	1.16	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.